SI1952805T1 - Tableta, ki vsebuje hidrogenirane fosfolipide - Google Patents

Tableta, ki vsebuje hidrogenirane fosfolipide

Info

Publication number
SI1952805T1
SI1952805T1 SI200830834T SI200830834T SI1952805T1 SI 1952805 T1 SI1952805 T1 SI 1952805T1 SI 200830834 T SI200830834 T SI 200830834T SI 200830834 T SI200830834 T SI 200830834T SI 1952805 T1 SI1952805 T1 SI 1952805T1
Authority
SI
Slovenia
Prior art keywords
tablet containing
containing hydrogenated
hydrogenated phospholipids
phospholipids
tablet
Prior art date
Application number
SI200830834T
Other languages
English (en)
Inventor
Ulrich Massing
Annette Bauer-Brandl
Original Assignee
Ktb-Tumorforschungs Gmbh
The University Of Tromsoe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ktb-Tumorforschungs Gmbh, The University Of Tromsoe filed Critical Ktb-Tumorforschungs Gmbh
Publication of SI1952805T1 publication Critical patent/SI1952805T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
SI200830834T 2007-01-23 2008-01-23 Tableta, ki vsebuje hidrogenirane fosfolipide SI1952805T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07101047A EP1952803A1 (en) 2007-01-23 2007-01-23 Solid pharmaceutical dosage form containing hydrogenated phospholipids
EP08100830A EP1952805B1 (en) 2007-01-23 2008-01-23 Tablet containing hydrogenated phospholipids

Publications (1)

Publication Number Publication Date
SI1952805T1 true SI1952805T1 (sl) 2013-07-31

Family

ID=38066929

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830834T SI1952805T1 (sl) 2007-01-23 2008-01-23 Tableta, ki vsebuje hidrogenirane fosfolipide

Country Status (4)

Country Link
US (1) US20080187583A1 (sl)
EP (2) EP1952803A1 (sl)
DK (1) DK1952805T3 (sl)
SI (1) SI1952805T1 (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1745788A1 (de) * 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acylglycerophospholipide zur Behandlung von Krebs und Tumorkachexie
US9907323B2 (en) 2015-09-25 2018-03-06 Mead Johnson Nutrition Co. Infant formula tablets
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
EP3991722A4 (en) * 2019-06-28 2022-10-05 Jiangsu Hengrui Medicine Co., Ltd. LIPID COMPOSITION WITH DELAYED RELEASE AND THEIR PROCESS OF PRODUCTION

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2057695A (en) * 1933-12-13 1936-10-20 American Lecithin Co Method for the production of vegetable phosphatide preparations
JPS5457820A (en) 1977-10-17 1979-05-10 Ricoh Co Ltd Pre-processing system for coding of pattern information
US4374082A (en) 1981-08-18 1983-02-15 Richard Hochschild Method for making a pharmaceutical and/or nutritional dosage form
US4882167A (en) 1983-05-31 1989-11-21 Jang Choong Gook Dry direct compression compositions for controlled release dosage forms
DE3613799C1 (de) * 1986-04-24 1987-09-03 Nattermann A & Cie Verwendung von Glycofurol zum Verfluessigen von Arzneimittelzubereitungen fuer das Abfuellen in Weichgelatinekapseln
JPS6348226A (ja) * 1986-08-14 1988-02-29 Ono Pharmaceut Co Ltd 徐放性を有する経口投与用固形製剤
US4762658A (en) 1986-10-08 1988-08-09 Central Soya Company, Inc. Method of tableting of de-oiled phosphatides (lecithin)
US5376381A (en) * 1988-02-25 1994-12-27 The Liposome Company, Inc. Integrity protected gelatin
GB2305604B (en) 1995-09-29 1999-06-23 Quest Vitamins Ltd Carrier base material
IL117773A (en) 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
AU1931999A (en) 1997-12-19 1999-07-12 Smithkline Beecham Corporation Process for manufacturing bite-dispersion tablets
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
JP2002532389A (ja) 1998-12-08 2002-10-02 ファレス ファーマシューティカル リサーチ エヌブイ リン脂質組成物
US20030161879A1 (en) 1999-06-29 2003-08-28 Shinji Ohmori Tablets quickly disintegrating in mouth
JP2003507410A (ja) 1999-08-25 2003-02-25 アドバンスト インハレーション リサーチ，インコーポレイテッド 乾燥粉末製剤からの放出調節
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
FR2814366A1 (fr) * 2000-09-22 2002-03-29 Rhodia Chimie Sa Procede de granulation de matieres actives par extrusion basse pression pour l'obtention de granules directement compressibles
JPWO2002034252A1 (ja) * 2000-10-26 2004-03-04 千寿製薬株式会社 ジペプチジルアルデヒド誘導体含有医薬組成物
WO2002096354A2 (en) 2001-05-29 2002-12-05 Tap Pharmaceutical Products Inc. Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin
AU2003257791A1 (en) 2002-08-15 2004-03-29 Tong Liu Soild nano pharmaceutical formulation and preparation method thereof
DE10340741A1 (de) 2003-09-04 2005-03-31 Degussa Food Ingredients Gmbh Formulierung auf Phospholipidbasis
JP5069001B2 (ja) * 2003-10-10 2012-11-07 ベロクシス ファーマシューティカルズ エー／エス フィブラートを含む固体投与形態
US20060182803A1 (en) * 2005-02-17 2006-08-17 Standard Chem. & Pharm. Co., Ltd. Oral sustained-release pharmaceutical composition of indapamide, production and use thereof
EP1745788A1 (de) 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acylglycerophospholipide zur Behandlung von Krebs und Tumorkachexie
US20110110984A1 (en) * 2006-11-10 2011-05-12 Alphaptose Gmbh Oral Dosage Form Comprising Tri-Substituted Glycerol Compounds

Also Published As

Publication number Publication date
EP1952803A1 (en) 2008-08-06
EP1952805A1 (en) 2008-08-06
US20080187583A1 (en) 2008-08-07
EP1952805B1 (en) 2012-08-29
DK1952805T3 (da) 2012-12-17

Similar Documents

Publication Publication Date Title
IL206171A0 (en) Tablet dispenser
GB2449359B (en) Holographic display
ZA201002255B (en) Orodispersible tablets
EP2172225A4 (en) SEAMLESS CAPSULE
GB2449505B (en) Tablet dispenser
GB0720730D0 (en) Soother
GB2452360B8 (en) Holgraphic display
SI2040684T1 (sl) Večenotne tablete
GB0721332D0 (en) Medicaments
PT1992575E (pt) Cápsula para produtos de infusão
ZA200904654B (en) Tablet formulation
GB0605104D0 (en) Tablet dispenser
SI1952805T1 (sl) Tableta, ki vsebuje hidrogenirane fosfolipide
SI2063312T1 (sl) Prikazovalna enota
GB0709235D0 (en) Display unit
TWI368808B (en) Display
EP2204693A4 (en) DISPLAY DEVICE
GB0608465D0 (en) Tablet dispenser
EP2050456A4 (en) COMPRESSED
GB0721333D0 (en) Medicaments
GB0717882D0 (en) Novel pharmaceutical
GB2445375B (en) Display
GB0713278D0 (en) Tablet dispenser
GB2449693B (en) Display unit
GB0816954D0 (en) Tablet holder